Authors:
Reagan, KE
Jensen, KF
Friedman, MA
Abou-Donia, MB
Citation: Ke. Reagan et al., Patterns of GAP-43 (B-50) expression and accumulation in subchronic acrylamide neurotoxicity, NEUROSC R C, 27(3), 2000, pp. 199-212
Authors:
Tyl, RW
Friedman, MA
Losco, PE
Fisher, LC
Johnson, KA
Strother, DE
Wolf, CH
Citation: Rw. Tyl et al., Rat two-generation reproduction and dominant lethal study of acrylamide indrinking water, REPROD TOX, 14(5), 2000, pp. 385-401
Authors:
Adler, ID
Baumgartner, A
Gonda, H
Friedman, MA
Skerhut, M
Citation: Id. Adler et al., 1-aminobenzotriazole inhibits acrylamide-induced dominant lethal effects in spermatids of male mice, MUTAGENESIS, 15(2), 2000, pp. 133-136
Authors:
Wilfley, DE
Friedman, MA
Dounchis, JZ
Stein, RI
Welch, RR
Ball, SA
Citation: De. Wilfley et al., Comorbid psychopathology in binge eating disorder: Relation to eating disorder severity at baseline and following treatment, J CONS CLIN, 68(4), 2000, pp. 641-649
Citation: Pa. Fail et al., Response of the pituitary and thyroid to tropic hormones in Sprague-Dawleyversus fischer 344 male rats, TOXICOL SCI, 52(1), 1999, pp. 107-121
Citation: Ma. Friedman, Regulatory issues in the evaluation of antimetastatic and other novel anticancer therapies, CANC CHEMOT, 43, 1999, pp. S100-S103
Authors:
Friedman, MA
Woodcock, J
Lumpkin, MM
Shuren, JE
Hass, AE
Thompson, LJ
Citation: Ma. Friedman et al., The safety of newly approved medicines - Do recent market removals mean there is a problem?, J AM MED A, 281(18), 1999, pp. 1728-1734